Biostar Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep '17 Sep 30, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Revenue	0.32	2.38	27.13	61.42	52.73	49.32
Revenue Growth (YoY)	-91.86%	-91.21%	-55.83%	16.48%	6.92%	-46.37%
Cost of Revenue	0.35	1.47	16.03	31.14	27.05	19.47
Gross Profit	-0.04	0.92	11.1	30.28	25.68	29.85
Selling, General & Admin	4.12	3.6	13.29	26.21	22.67	33.84
Research & Development	1.14	1.14	4.02	2.77	3.23	4.48
Operating Expenses	-2.82	4.48	21.98	28.97	24.93	41.99
Operating Income	2.79	-3.56	-10.87	1.31	0.75	-12.14
Interest Expense	-0.2	-0.21	-0.28	-0.15	-0.37	-0.08
Interest & Investment Income	0	0	0.01	1.33	1.34	0.3
Other Non Operating Income (Expenses)	0.5	0.22	0.24	0	0	0
EBT Excluding Unusual Items	3.09	-3.55	-10.91	2.48	1.73	-11.93
Gain (Loss) on Sale of Assets	-	-	-	1.09	1.17	-
Asset Writedown	-	-	-2.97	-2.62	-0.24	-
Legal Settlements	0.5	0.5	-	-	-	-
Other Unusual Items	-	-	-9.91	0.58	-	-9.65
Pretax Income	3.59	-3.05	-23.79	1.53	2.66	-21.57
Income Tax Expense	2.65	2.65	1.32	-3.31	1.85	-1.58
Net Income	0.93	-5.7	-25.11	4.85	0.81	-20
Net Income to Common	0.93	-5.7	-25.11	4.85	0.81	-20
Net Income Growth	-	-	-	499.25%	-	-
Shares Outstanding (Basic)	3	2	2	2	2	1
Shares Outstanding (Diluted)	3	2	2	2	2	1
Shares Change (YoY)	18.37%	3.91%	6.74%	25.96%	20.27%	2.93%
EPS (Basic)	0.36	-2.48	-11.36	2.34	0.49	-14.63
EPS (Diluted)	0.34	-2.50	-11.40	2.30	0.49	-14.63
EPS Growth	-	-	-	369.39%	-	-
Free Cash Flow	8.59	4.91	5.82	0.44	7.93	-3.62
Free Cash Flow Per Share	3.28	2.14	2.63	0.21	4.82	-2.65
Gross Margin	-11.56%	38.38%	40.93%	49.30%	48.71%	60.53%
Operating Margin	876.46%	-149.48%	-40.07%	2.13%	1.42%	-24.62%
Profit Margin	294.01%	-238.98%	-92.56%	7.89%	1.53%	-40.55%
Free Cash Flow Margin	2702.11%	206.03%	21.44%	0.72%	15.03%	-7.33%
EBITDA	3.89	-2.42	-8.55	4.39	3.54	-10.31
EBITDA Margin	1225.43%	-101.56%	-31.52%	7.15%	6.70%	-20.91%
D&A For EBITDA	1.11	1.14	2.32	3.09	2.79	1.83
EBIT	2.79	-3.56	-10.87	1.31	0.75	-12.14
EBIT Margin	876.46%	-149.48%	-40.07%	2.13%	1.42%	-24.62%
Effective Tax Rate	73.95%	-	-	-	69.54%	-
Advertising Expenses	-	-	3.8	8.59	7.56	14.15

Source: S&P Global Market Intelligence. Standard template. Financial Sources.